Recorded Chinese product: 依替磷膦二钠片依替磷膦二钠片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 扬州中宝制药有限公司Chinese legal name: 扬州中宝制药有限公司
主要成分Active Ingredients
- 羟乙膦酸钠Qiangyi Linsuan Na
药物知识说明
羟乙膦酸钠是一种在国家药监局注册认定的药品。该药品含有羟乙膦酸钠-99094fc6等成分。
该药品关联的活性成分包括：羟乙膦酸钠Qiangyi Linsuan Na。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：扬州中宝制药有限公司Chinese legal name: 扬州中宝制药有限公司。
您可以探索含有相同成分的其他药品：羟乙膦酸钠-99094fc6成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 依替磷膦二钠片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 羟乙膦酸钠Qiangyi Linsuan Na.
Manufacturers recorded for this product: 扬州中宝制药有限公司Chinese legal name: 扬州中宝制药有限公司.
Explore other medicines containing the same ingredient: 羟乙膦酸钠 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 依替磷膦二钠片Recorded Chinese product: 依替磷膦二钠片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 0.2g0.2 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 扬州中宝制药有限公司Chinese legal name: 扬州中宝制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H19991409
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H19991409
Manufacturer
Chinese legal name: 扬州中宝制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H19991409
生产企业
扬州中宝制药有限公司(国产)
适应症
用于绝经后骨质疏松症和增龄性骨质疏松症。
用法用量
口服：一次0.2g，一日2次，两餐间服用。
不良反应
腹部不适，腹泻，呕吐，口炎，头痛，咽喉灼热感，瘙痒，皮疹等症状。
禁忌
严重肾损害者、骨软化症患者禁用。
注意事项
1．需间隙，周期性服药，服药两周后需停药十一周为一周期，然后又重新开始第二周期，停药期间需补充钙剂及维生素D3。长期服用请遵医嘱。 |2．在服用本品两小时内，避免食用高钙食品（例如牛奶或奶制品）和含矿物质的维生素或抗酸药。 |3．肾功能损害，消化性溃疡，肠炎等患者慎用。 |4．若出现皮肤瘙痒，皮疹等过敏症状时应停止用药。
贮藏
密封，干燥处保存。
规格
0.2g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.